Abstract:Background and objective: Genetic polymorphism studies in families and twins indicated the heritability of depression. However, the association between genes with genetic polymorphism and depression provides various findings and remains unclear. Therefore, we conducted a systematic review and meta-analysis to determine the genes with their polymorphism associated with the symptomatic depression known as major depressive disorder (MDD). Materials and methods: PubMed and Scopus were searched for relevant studies published before May 22, 2023 (1968-2023), and 62 were selected for this review. The study's bias risk was investigated using the Newcastle-Ottawa scale. Gene functional enrichment analysis was investigated for molecular function (MF) and biological process (BP) and pathways. A meta-analysis of the studied genes that were replicative in the same single nucleotide polymorphism was conducted using a random-effect model. Results: The 49 genes involved in MDD were studied and engaged in several pathways, such as tryptophan metabolism or dopaminergic and serotonergic synapses. Based on gene overlapping in MF and BP, 13 genes with polymorphisms were identified as related to MDD. Most of them were only studied once. Solute carrier family 6 member 4 (SLC6A4) overlapping between MF and BP and brain-derived neurotrophic factor (BDNF) as unique to BP were replicative studied and used in the meta-analysis. The polymorphism of SLC6A4 SS and LS genotypes increased the occurrence of MDD development but not significantly [odd ratio (OR) = 1.39; 95% confidence interval (CI) = 0.87-2.22; P = 0.16 and OR = 1.13; 95% CI = 0.84-1.53; P = 0.42, respectively]. A similar result was observed for BDNF rs6265 GG (OR = 1.26; 95% CI = 0.78-2.06; P = 0.35) and BDNF rs6265 AA genotypes (OR = 1.12; 95% CI = 0.77-1.64; P = 0.56). These studies indicated low bias and significant heterogeneity. Conclusion: At least 13 studied genes with polymorphisms were involved in MDD development according to MF and BP, but not significantly. These results suggest that MDD development risk factors might require genetic and other factors for interaction and induction.

Serotonergic genes modulate amygdala activity in major depression

5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression

Serotonin Transporter Genotype Modulates Functional Connectivity Between Amygdala and PCC/PCu During Mood Recovery

Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways

Serotonergic gene expression and depression: implications for developing novel antidepressants

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning

Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response

Association study on 5-HT 2A receptor gene T102C polymorphism and the concentration of gray matter in patients with major depressive disorder

The contribution of BDNF and 5-HTT polymorphisms and early life stress to the heterogeneity of major depressive disorder: a preliminary study

Association between polymorphism of serotonin transporter gene and adolescent depression

Effects of serotonin transporter and receptor polymorphisms on depression

Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis

Genome-wide gene-gene interaction of the 5-HTTLPR promoter polymorphism emphasizes the important role of neuroplasticity in depression

[Association between serotonin transporter and monoamine oxidase A gene polymorphisms and depression]

Genetic variation of the 5-HT1A rs6295, 5-HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients

Association of Serotonin and Norepinephrine Transporter Gene Polymorphisms with the Susceptibility to Depression

Serotonin Transporter Gene: A New Polymorphism May Affect Response to Antidepressant Treatments in Major Depressive Disorder

Tryptophan Hydroxylase Gene Polymorphism and the Imaging Manifestation in Subregions of Frontal Lobes in Patients with Depressive Disorder

Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression